Oral ulcers are highly prevalent mucosal disorders that cause significant pain and discomfort. However, current therapies often fail because saliva quickly washes away topical medications. Researchers have recently developed a revolutionary oral ulcer treatment using an amylase-responsive bilayer film (PZ/SP). This innovative biomaterial platform addresses the limitations of retention time and bioavailability in the oral cavity.

The system consists of a starch-pectin matrix integrated with catechol-zinc (PA-Zn) nano-enzymes. Specifically, salivary amylase triggers the progressive degradation of the inner starch layer. This mechanism ensures a sustained and controlled release of therapeutic enzymes directly at the ulcer site. Meanwhile, the outer pectin layer maintains the structural integrity of the film against the harsh oral environment. Consequently, the drug stays in contact with the wound for a much longer duration than traditional gels.

Advancements in Oral Ulcer Treatment

This film demonstrates a unique dual-phase therapeutic action. First, it provides effective scavenging of reactive oxygen species (ROS) through superoxide dismutase (SOD)-mimicking activity. Furthermore, it actively modulates the inflammatory response. It promotes the polarization of macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype. Therefore, it creates an ideal microenvironment for tissue repair rather than just providing a physical barrier.

In vivo studies using murine models have confirmed the efficacy of this film. The PZ/SP film significantly extends the retention of enzymes compared to standard treatments. Additionally, it reduces oxidative stress and accelerates healing by enhancing re-epithelialization and angiogenesis. Moreover, this responsive biomaterial offers a promising new strategy for oral mucosal regeneration. Thus, it represents a major clinical advancement for patients suffering from chronic or recurrent ulceration.

Frequently Asked Questions

How does the amylase-responsive mechanism improve treatment?

Salivary amylase naturally breaks down the starch layer of the film. This allows the medication to release slowly and only when in contact with saliva, ensuring the drug is not wasted and remains effective for longer periods.

What is the role of ROS scavenging in healing?

Excessive reactive oxygen species (ROS) cause oxidative stress, which delays wound healing and increases inflammation. By scavenging these molecules, the film reduces tissue damage and helps the ulcer heal faster.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Liu X et al. An amylase-responsive bilayer film for sustained enzyme delivery and ROS-scavenging therapy in oral ulcer treatment. J Mater Chem B. 2026 Apr 16. doi: 10.1039/d5tb02515j. PMID: 41989817.

2. Hu S et al. A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery. Nat Commun. 2021 Mar 16;12(1):1682.

3. Xu J et al. Localized treatment of oral ulcers via responsive microneedle patch by enhancing mucosal penetration. Int J Pharm. 2026 Jan 18;689:126598.